Medicines & HealthCare (EDQM), Council of Europe: Blood Transfusion Activities
Mission
The work of the Council of Europe in the blood transfusion area started in the 1950s. From the outset, the activities were inspired by the following guiding principles: promotion of voluntary, non-remunerated blood donation, mutual assistance, optimal use of blood and blood products, and protection of the donor and recipient.
In 2007, the scientific secretariat responsible for blood transfusion activities at the Council of Europe was transferred to the EDQM 1 and the European Committee on Blood Transfusion (CD-P-TS) was given the duty to steer and co-ordinate all activities of the Council of Europe 2 in the field of blood transfusion.
Membership Council of Europe member states and parties to the European Pharmacopoeia 3 Convention are represented in the CD-P-TS and its subordinate expert group. Non- European observer countries to the European Pharmacopoeia 3 Convention, including Australia, Canada, the USA, and the European Commission, the World Health Organization (WHO) and representatives of related and relevant Council of Europe Committees (e.g. European Bioethics Committees) are privileged observers to the CD- P-TS.
European Committee on Blood Transfusion (CD-P-TS)
The European Committee on Blood Transfusion (CD-P-TS) undertakes to: examine questions related to human blood transfusion, notably on quality and safety standards and their implementation in the different member states; assist members states in improving blood transfusion services and, if needed, in restructuring their blood transfusion services to promote the principle of voluntary non-remunerated donations; define and promote the implementation of quality and safety standards in the collection, storage, distribution and use of blood and blood components; propose ethical, safety and quality standards on professional practices and product specifications; ensure the transfer of knowledge and expertise and develop the competencies of experts through training and networking; establish good practices in transfusion medicine and monitor their use in Europe; assess epidemiological risks linked to blood and its components, in particular for new transmissible diseases;
1 The European Directorate for the Quality of Medicines & HealthCare contributes to protecting and promoting public and animal health in Europe by establishing high quality standards for human and veterinary medicinal products, blood transfusion and organ transplantations, and the safe and appropriate use of medicines. 2 A political organisation set up in 1949, the Council of Europe works to promote democracy and human rights continent-wide. It also develops common responses to social, cultural and legal challenges in its 47 member states. 3 Algeria, Argentina, Australia, Brazil, Canada, China, Israel, Madagascar, Malaysia, Morocco, Senegal, Syria, Tunisia, United States of America.
ensure the availability of rare blood products by providing appropriate and adapted tools such as the European Bank of Frozen Blood of Rare Groups or other appropriate databases. The CD-P-TS meets at least once a year in a plenary session.
Major Resolutions
Resolution CM/Res (2008)5 on donor responsibility and on limitations to donation of blood and blood components, adopted by the Committee of Ministers on 12 March 2008. Resolution CM/Res (2013) on sexual behaviours of blood donors that have an impact on transfusion safety, adopted by the Committee of Ministers on 27 March 2013.
Landmark Texts
Terms of reference for 2014-2015 adopted on 21 November 2013 by the Committee of Ministers of the Council of Europe. Annual Report on the Collection, Testing and Use of Blood and Blood Components in Europe, from 2001 to 2011. Trends and Observations on the Collection, Testing and Use of Blood and Blood Components from Council of Europe member states, 2001-2011. Good Practice Guidelines for Blood Establishments and Hospital Blood Banks Required to Comply with EU Directive 2005/62/EC, adopted by the European Committee on Blood Transfusion (CD-P-TS) of the Council of Europe in November 2013. These Guidelines will become an integral part of the Guide to the preparation, use and quality assurance of blood components as of the 18 th Edition.
Recent Publications
Guide to the preparation, use and quality assurance of blood components 17 th Edition (2013). The guide contains recommendations on blood collection, blood components, technical procedures, transfusion practices and quality systems for blood establishments and, thus, describes a set of measures designed to ensure the safety, quality and efficacy of blood components. It represents a key milestone in defining the gold standard for blood transfusion services.
Contact
Dr Guy Rautmann, Scientific Officer, Department of Biological Standardisation and Official Medicines Control Laboratories Network (DBO), EDQM, Council of Europe. E-mail: Guy.Rautmann@edqm.eu Tel.: + 33 (0)3 88 41 36 39 Fax: + 33 (0)3 88 41 27 71 Please do not hesitate to contact us via our HelpDesk: www.edqm.eu/hd